{{Infobox enzyme
| Name = Chymopapain
| EC_number = 3.4.22.6
| CAS_number = 2593837
| IUBMB_EC_number = 3/4/22/6
| GO_code = 
| image = 1yal.jpg
| width = 200
| caption = Chymopapain's structure
}}
{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 477380130
| IUPAC_name =  
| image =  
<!-- Clinical data -->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US =  
| pregnancy_category =  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled -->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status = Rx-only
| routes_of_administration = [[Injection (medicine)|Injection]] into [[intervertebral disc]]
<!-- Pharmacokinetic data -->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  
<!-- Identifiers -->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number =  
| ATC_prefix = M09
| ATC_suffix = AB01
| ATC_supplemental =  
| PubChem =  
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 1UK146T40N
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1201626
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = none
<!-- Chemical data -->
| chemical_formula =   | C= | H= | N= | O=| molecular_weight =  
| smiles =  
}}
'''Chymopapain''' ({{EC number|3.4.22.6}}, ''chymopapain A'', ''chymopapain B'', ''chymopapain S'', brand name '''Chymodiactin''') is a [[proteolytic enzyme]] isolated from the [[latex]] of [[papaya]] (''Carica papaya'').  It is a medication used to treat [[hernia]]ted lower [[lumbar]] discs in the spine.<ref>[http://www.medicinenet.com/chymopapain-injection/article.htm#Uses Chymopapain Injection from MedicineNet]</ref> Chymopapain injections are normally given under local, rather than general, [[anaesthesia]]. The dose for a single [[intervertebral disc]] is 2 to 4 nano[[katal]]s, with a maximum dose per patient of 8 nanokatals. The procedure is referred to as chemonucleolysis.

The sale and distribution of chymopapain was discontinued in the United States on January 27, 2003 after the company producing it decided to stop selling worldwide.<ref>[http://www.mayoclinic.com/health/drug-information/DR600373 http://www.mayoclinic.com/health/drug-information/DR600373]</ref><ref>[http://www.sciatica.com/physician--information/scientific-articles/file/24-the-current-status-of-chymopapain.html The Current Status of Chymopapain]</ref>

==Side effects==
Serious side effects from the use of chymopapain include [[anaphylaxis]], [[paralysis]] of the legs, or [[death]].<ref> [http://www.mayoclinic.com/health/drug-information/DR600373 http://www.mayoclinic.com/health/drug-information/DR600373] </ref>

==See also==
*[[Papain]]

==References==
<references/>

==External links==
*The [[MEROPS]] online database for peptidases and their inhibitors: [http://merops.sanger.ac.uk/cgi-bin/merops.cgi?id=C01.002 C01.002]
*[http://www.biozym.de/datasheets/papain.php Data sheet for Papain from BIOZYM]

{{Cysteine proteases}}
{{Enzymes}}
{{Portal bar|Molecular and Cellular Biology|border=no}}

{{musculoskeletal-drug-stub}}
{{enzyme-stub}}

[[Category:Enzymes used as drugs]]
[[Category:Drugs acting on the musculoskeletal system]]
[[Category:EC 3.4.22]]